Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.

Abstract:

:In January, 1972, the Southwest Oncology Group initiated two randomized studies for patients with advanced breast cancer. The study for patients with prior chemotherapy showed a 33% response rate with adriamycin. The study for patients without previous chemotherapy consisted of three treatment regimens; a weekly repeated combination of cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone; these same five drugs given in courses of 5 days repeated every 4 weeks; and adriamycin as a single agent every 3 weeks. For the 283 evaluable patients, the response rates were: weekly combination 63/106 (59%); intermittent combination 39/98 (40%); and adriamycin 31/79 (39%). The median duration of response was 8 months for weekly combination, 10 months for intermittent therapy and only 4 months for adriamycin. Leukopenia was the dose-limiting toxicity with all three regimens. The weekly combination is the most effective therapy for patients with advanced disease. Extensive trails of combinations that include adriamycin are underway.

journal_name

Cancer

journal_title

Cancer

authors

Hoogstraten B,George SL,Samal B,Rivkin SE,Costanzi JJ,Bonnet JD,Thigpen T,Braine H

doi

10.1002/1097-0142(197607)38:1<13::aid-cncr28203801

subject

Has Abstract

pub_date

1976-07-01 00:00:00

pages

13-20

issue

1

eissn

0008-543X

issn

1097-0142

journal_volume

38

pub_type

临床试验,杂志文章,随机对照试验

相关文献

CANCER文献大全
  • Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.

    abstract::The therapeutic effect of prednimustine was studied in 35 patients with advanced breast cancer resistant to previous cytotoxic and/or endocrine therapy. Response (PR + CR) was obtained in 14 patients (40%) of a median duration of five months. Among the 14 responding patients, 10 were resistant to previous endocrine th...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800715)46:2<253::aid-cncr28204

    authors: Mouridsen HT,Kristensen D,Nielsen JH,Dombernowsky P

    更新日期:1980-07-15 00:00:00

  • Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.

    abstract:BACKGROUND:The effect on prognosis of adding imatinib mesylate to the treatment of patients with Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML) has not been explored fully. The objective of the current study was to evaluate the benefit of adding imatinib to the treatment sequence of patients w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11665

    authors: Kantarjian H,O'Brien S,Cortes J,Shan J,Giles F,Garcia-Manero G,Verstovsek S,Faderl S,Rios MB,Talpaz M

    更新日期:2003-10-01 00:00:00

  • Patterns of Care Study quantitative evaluation of the quality of radiotherapy in Japan.

    abstract:BACKGROUND:Quality assurance (QA) of clinical practice is important for any medical specialty. Programs based on the Patterns of Care Study (PCS) have been developed to compare the quality of radiotherapeutic care at individual institutions, with the national average representing the process and outcome of radiotherapy...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10633

    authors: Tanisada K,Teshima T,Ohno Y,Inoue T,Abe M,Ikeda H,Owen JB,Hanks GE,Masuda K,Honke Y

    更新日期:2002-07-01 00:00:00

  • Guideline implementation for breast healthcare in low- and middle-income countries: breast healthcare program resource allocation.

    abstract::Breast cancer is serious public health problem in countries of all resource levels. Although major advances in the detection and treatment of the disease have occurred in higher income settings, similar progress has been slow or scarce in most low- and middle-income countries (LMCs). The poorer outcomes in LMCs may re...

    journal_title:Cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1002/cncr.23841

    authors: Harford J,Azavedo E,Fischietto M,Breast Health Global Initiative Healthcare Systems Panel.

    更新日期:2008-10-15 00:00:00

  • Methotrexate: an active drug in bladder cancer.

    abstract::Forty-nine patients with transitional urothelial tract tumors received methotrexate: 0.5-1.0 mg/kg I.V. Q W (40 patients) or 250 mg/M2 in a 2-hour infusion with citrovorum factor rescue 24 hours later (nine patients). Eleven (26%, 95% confidence limits 13-39%) of 42 patients with bidimensionally measurable metastases ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810315)47:6<1246::aid-cncr2820

    authors: Natale RB,Yagoda A,Watson RC,Whitmore WF,Blumenreich M,Braun DW Jr

    更新日期:1981-03-15 00:00:00

  • Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population.

    abstract:BACKGROUND:Pelvic irradiation to patients with prostate cancer is accompanied by urinary and intestinal reactions. In men older than 60 years, treatment-induced problems should be evaluated in relation to problems in an age-matched nonirradiated population. METHODS:In the present study, problems in the urinary tract a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19941101)74:9<2520::aid-cncr2820

    authors: Widmark A,Fransson P,Tavelin B

    更新日期:1994-11-01 00:00:00

  • Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer.

    abstract:BACKGROUND:Local recurrence is the most frequent site of failure after resection for pancreatic cancer. Tolerance, local control, and survival obtained by the association of resection and intraoperative radiation therapy (IORT) were reported. METHODS:Between June 1985 and March 1993, 90 resections for pancreatic cance...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19940615)73:12<2930::aid-cncr282

    authors: Zerbi A,Fossati V,Parolini D,Carlucci M,Balzano G,Bordogna G,Staudacher C,Di Carlo V

    更新日期:1994-06-15 00:00:00

  • Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapy.

    abstract::Sixty-two patients with acute leukemia who remained in continuous complete remission for 8 to 45 months received three courses of intensified therapy with new chemotherapeutic agents, after which they received no further chemotherapy. Immunotherapy with BCG was then administered to 55 of these patients. They have been...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810415)47:8<1937::aid-cncr2820

    authors: Bodey GP,Freireich EJ,McCredie KB,Smith TL,Gehan EA,Gutterman JU,Hersh EM

    更新日期:1981-04-15 00:00:00

  • Antitumor electrochemotherapy: new advances in the clinical protocol.

    abstract:BACKGROUND:Electrochemotherapy (ECT) is a new antitumor approach that combines systemic bleomycin (BLM) with electric pulses (EP) delivered locally at the tumor site. These EP permeabilize the cells in the tissue, allow BLM delivery inside the cells, and increase BLM cytotoxicity. As an extension of our initial Phase I...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/(sici)1097-0142(19960301)77:5<956::aid-cnc

    authors: Domenge C,Orlowski S,Luboinski B,De Baere T,Schwaab G,Belehradek J Jr,Mir LM

    更新日期:1996-03-01 00:00:00

  • Intraoperative radiotherapy for intracranial malignancies. A pilot study.

    abstract::Intraoperative radiotherapy (IOR) or "direct view" irradiation permits the delivery of a single exposure of high-energy electrons to a surgically exposed tumor. Surgical exposure permits physical retraction of normal uninvolved tissues away from the IOR beam as well as the accurate assessment of the target volume. IOR...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19841201)54:2+<2807::aid-cncr282

    authors: Goldson AL,Streeter OE Jr,Ashayeri E,Collier-Manning J,Barber JB,Fan KJ

    更新日期:1984-12-01 00:00:00

  • Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma.

    abstract:BACKGROUND:The carboplatin-based chemotherapeutic regimen M-CAVI (methotrexate, carboplatin, and vinblastine) is active against bladder carcinoma and can be administered to patients who are ineligible to receive cisplatin or doxorubicin. The authors designed a randomized study to evaluate whether M-CAVI offers a therap...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/(sici)1097-0142(19971115)80:10<1966::aid-c

    authors: Bellmunt J,Ribas A,Eres N,Albanell J,Almanza C,Bermejo B,Solé LA,Baselga J

    更新日期:1997-11-15 00:00:00

  • Human immunodeficiency virus-associated Hodgkin's disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells.

    abstract::Hodgkin's disease (HD) was diagnosed in 24 patients who were either seropositive for human immunodeficiency virus (HIV) (21) or members of a high-risk group (three), but had not developed acquired immune deficiency syndrome (AIDS). Clinical presentation of the disease was characterized by constitutional symptoms in al...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910315)67:6<1614::aid-cncr2820

    authors: Ree HJ,Strauchen JA,Khan AA,Gold JE,Crowley JP,Kahn H,Zalusky R

    更新日期:1991-03-15 00:00:00

  • HBAg-positive chronic liver disease associated with cirrhosis and hepatocellular carcinoma in the Senoi.

    abstract::Necropsy and clinical data show that primary hepatocellular carcinoma (PHC) is the commonest cancer among the Senoi (a Malaysian aboringine group). The other aboringine tribes do not appear to have this high predilection for liver cancer. In the necropsy series, PHS was present in 10 out of 22 Senoi patients with cirr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197710)40:4<1618::aid-cncr282040

    authors: Sumithran E,Prathap K

    更新日期:1977-10-01 00:00:00

  • A phase I study of chlorozotocin (NSC 178248).

    abstract::Chlorozotocin was administered by rapid intravenous infusion to 35 patients with advanced cancer on either single-day of five-consecutive-day schedules. Total doses per course ranged from 12.5 to 200 mg/m2. On either administration schedule, dose limiting toxicities were thrombocytopenia and leukopenia at total doses ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197906)43:6<2189::aid-cncr282043

    authors: Kovach JS,Moertel CG,Schutt AJ,Frytak S,O'Connell MJ,Rubin J,Ingle JN

    更新日期:1979-06-01 00:00:00

  • Angiosarcoma in Japan. A review of 99 cases.

    abstract:BACKGROUND:Angiosarcoma is rare, and information about its clinical features are limited. Therefore, a large scale study of angiosarcoma was performed in Japan. METHODS:Through a nationwide Japanese study, 99 cases of angiosarcoma were collected and their clinicopathologic findings were summarized relative to predispo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950215)75:4<989::aid-cncr28207

    authors: Naka N,Ohsawa M,Tomita Y,Kanno H,Uchida A,Aozasa K

    更新日期:1995-02-15 00:00:00

  • Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods.

    abstract::Grilled or fried meat and fish contain various mutagenic heterocyclic amines, and structures of at least 19 compounds have already been determined. Among these, 10 have been examined for long term carcinogenicity, all proving to be positive. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), for example, preferen...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940801)74:3+<1063::aid-cncr282

    authors: Nagao M,Ushijima T,Wakabayashi K,Ochiai M,Kushida H,Sugimura T,Hasegawa R,Shirai T,Ito N

    更新日期:1994-08-01 00:00:00

  • Molecular biology in cytopathology: current applications and future directions.

    abstract::The use of molecular techniques in cytopathology has become an accepted and billable practice for certain applications. Other applications still are in the developmental or experimental stages but may soon be clinically useful. The current study provides a review of these techniques including molecular detection of cl...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/(sici)1097-0142(20000225)90:1<1::aid-cncr1

    authors: Rimm DL

    更新日期:2000-02-25 00:00:00

  • Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.

    abstract:BACKGROUND:Vascular endothelial growth factor C (VEGF-C) plays an important role in lymphangiogenesis and activates VEGF receptor 3 (VEGFR-3). By contrast, lymphatic spread is an important prognostic factor in patients with nonsmall cell lung carcinoma (NSCLC). The objective of the current study was to determine whethe...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11073

    authors: Arinaga M,Noguchi T,Takeno S,Chujo M,Miura T,Uchida Y

    更新日期:2003-01-15 00:00:00

  • Basosquamous (transitional cloacogenic) carcinoma of the sigmoid colon.

    abstract::A case of basosquamous or so-called transitional cloacogenic carcinoma of the sigmoid colon, which arose above the pelvic brim at the peritoneal reflection, is reported. We were not able to find a report of this histologic type of tumor arising this far from the pectinate line of the anus, which is the most common pri...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197709)40:3<1234::aid-cncr282040

    authors: Strate RW,Richardson JD,Bannayan GA

    更新日期:1977-09-01 00:00:00

  • Patterns of second malignant neoplasms in children.

    abstract::A search of the records of 10 pediatric oncology centers revealed 102 children with more than one malignant neoplasm. In this group of 102 patients, all pediatric cancers were seen as initial lesions, but Wilms' tumor and retinoblastoma were over-represented and leukemia and brain tumors underrepresented. Survival var...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197710)40:4+<1903::aid-cncr28204

    authors: Meadows AT,D'Angio GJ,Miké V,Banfi A,Harris C,Jenkin RD,Schwartz A

    更新日期:1977-10-01 00:00:00

  • The problem of neck relapse in early stage supraglottic larynx cancer.

    abstract::We reviewed the records of 104 patients with Stage T1NO or Stage T2NO epidermoid carcinoma of the supraglottic larynx treated between 1965 and 1979. In 79 patients, surgery was the only type of initial treatment. These 79 patients are the subjects of this report. Forty-eight (61%) of these patients were treated by tot...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890115)63:2<345::aid-cncr28206

    authors: Levendag P,Sessions R,Vikram B,Strong EW,Shah JP,Spiro R,Gerold F

    更新日期:1989-01-15 00:00:00

  • Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival.

    abstract:BACKGROUND:Patients with renal cell carcinoma brain metastases (RCCBM) are frequently excluded from trials and to the authors' knowledge no guidelines currently exist regarding central nervous system (CNS) surveillance or treatment. The objective of the current study was to assist in the creation of treatment guideline...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23769

    authors: Shuch B,La Rochelle JC,Klatte T,Riggs SB,Liu W,Kabbinavar FF,Pantuck AJ,Belldegrun AS

    更新日期:2008-10-01 00:00:00

  • Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009.

    abstract:BACKGROUND:Ideally, screening detects cancer at a more curable stage and, as a result, decreases the rate of subsequent diagnosis at a late stage. Although it is suggested that some cancer screening tests have led to substantial increases in early-stage incidence with only marginal reductions in late-stage incidence (e...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28794

    authors: Yang DX,Gross CP,Soulos PR,Yu JB

    更新日期:2014-09-15 00:00:00

  • Paclitaxel-based second-line therapy for patients with advanced chemotherapy-resistant bladder carcinoma (M1): a clinical Phase II study.

    abstract:BACKGROUND:In a previous clinical trial, the authors disclosed that the expression of tumor cell motility factor gp78hAMFR correlates with tumor progression in patients with bladder carcinoma. This study was initiated to evaluate whether the combination of cytostatic drugs with an antimotility factor has an effect on c...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/(sici)1097-0142(19970801)80:3<465::aid-cnc

    authors: Otto T,Bex A,Krege S,Walz PH,Rübben H

    更新日期:1997-08-01 00:00:00

  • Epithelial papilloma and squamous cell carcinoma of the nasal cavity and paranasal sinuses: a clinicopathological study.

    abstract::Seventeen cases of intranasal epithelial tumors are reviewed. Thirteen were epithelial papillomas and four were squamous cell carcinomas associated with epithelial papillomas. In two cases followed over a 10 year period, transformation from an initial papilloma into a carcinoma was demonstrated. The histopathologic ca...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197612)38:6<2503::aid-cncr282038

    authors: Lasser A,Rothfeld PR,Shapiro RS

    更新日期:1976-12-01 00:00:00

  • Identification of genes that are regulated transcriptionally by Myc in childhood tumors.

    abstract:BACKGROUND:Amplification of the N-myc oncogene is associated with adverse outcomes in the common childhood tumor, neuroblastoma. Because the transforming properties of Myc are related to its ability to modulate gene expression, the authors used cDNA microarrays to identify potential Myc target genes. METHODS:Expressio...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11584

    authors: Raetz EA,Kim MK,Moos P,Carlson M,Bruggers C,Hooper DK,Foot L,Liu T,Seeger R,Carroll WL

    更新日期:2003-08-15 00:00:00

  • Preoperative and postoperative immunological evaluation of patients with colorectal cancer.

    abstract::Twenty-two patients with cancer of the colon and rectum were studied: preoperative and postoperative cell-mediated and humoral immune factors were assessed, and local concentration of immunoglobulins in tumor tissue and in normal mucosa were measured. Lymphocyte function was found to be reduced in 50% of stage A and B...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800815)46:4<700::aid-cncr28204

    authors: Shafir M,Bekesi JG,Papatestas A,Slater G,Aufses AH Jr

    更新日期:1980-08-15 00:00:00

  • Secular and age distribution of scrotal cancer in Connecticut and a review of United States literature.

    abstract::In contrast with the expectations of the authors and with reports suggesting a decline in risk for scrotal cancer, Connecticut Tumor Registry data neither showed detectable decrease in risk over the 45-year-period for all 95 scrotal malignancies nor for the 71 epithelial cancers. The age distribution of scrotal cancer...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840801)54:3<596::aid-cncr28205

    authors: Roush GC,Schymura MJ,Flannery JT

    更新日期:1984-08-01 00:00:00

  • Long-term surgical outcomes of temporal lobe epilepsy associated with low-grade brain tumors.

    abstract:BACKGROUND:Tumor-related temporal lobe epilepsy (TLE) has a high likelihood of medical intractability and requires surgical treatment. The aims of this study were to analyze the long-term surgical outcomes of and to present appropriate surgical strategies for tumor-related TLE. METHODS:The clinical data of 87 consecut...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24666

    authors: Phi JH,Kim SK,Cho BK,Lee SY,Park SY,Park SJ,Lee SK,Kim KJ,Chung CK

    更新日期:2009-12-15 00:00:00

  • Interleukin-6 and its receptor in cancer: implications for translational therapeutics.

    abstract::Interleukin-6 (IL-6) plays a major role in the response to injury or infection and is involved in the immune response, inflammation, and hematopoiesis. Its deregulation impacts numerous disease states, including many types of cancer. Consequently, modulating IL-6 may be an innovative therapeutic strategy in several di...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.22999

    authors: Hong DS,Angelo LS,Kurzrock R

    更新日期:2007-11-01 00:00:00